First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
Clinical trial NCT06586697 · UNKNOWN
Trial details
- NCT number
- NCT06586697
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-01-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.